Kim SG - Search Results

1

Identification of a novel class of dithiolethiones that prevent hepatic insulin resistance via the adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathway.

Bae EJ, Yang YM, Kim JW, Kim SG. Bae EJ, et al. Among authors: kim sg, kim jw. Hepatology. 2007 Sep;46(3):730-9. doi: 10.1002/hep.21769. Hepatology. 2007. PMID: 17668885

2

Essential role of phosphatidylinositol 3-kinase-dependent CCAAT/enhancer binding protein beta activation in the induction of glutathione S-transferase by oltipraz.

Kang KW, Cho IJ, Lee CH, Kim SG. Kang KW, et al. Among authors: kim sg. J Natl Cancer Inst. 2003 Jan 1;95(1):53-66. doi: 10.1093/jnci/95.1.53. J Natl Cancer Inst. 2003. PMID: 12509401

3

Hepatocyte growth factor activates CCAAT enhancer binding protein and cell replication via PI3-kinase pathway.

Cho MK, Kim SG. Cho MK, et al. Among authors: kim sg. Hepatology. 2003 Mar;37(3):686-95. doi: 10.1053/jhep.2003.50078. Hepatology. 2003. PMID: 12601366

4

Enhanced CCAAT/enhancer-binding protein beta-liver-enriched inhibitory protein production by Oltipraz, which accompanies CUG repeat-binding protein-1 (CUGBP1) RNA-binding protein activation, leads to inhibition of preadipocyte differentiation.

Bae EJ, Kim SG. Bae EJ, et al. Among authors: kim sg. Mol Pharmacol. 2005 Sep;68(3):660-9. doi: 10.1124/mol.105.012997. Epub 2005 Jun 16. Mol Pharmacol. 2005. PMID: 15961673

5

Role of p90 ribosomal S6-kinase-1 in oltipraz-induced specific phosphorylation of CCAAT/enhancer binding protein-beta for GSTA2 gene transactivation.

Lee SJ, Kim SG. Lee SJ, et al. Among authors: kim sg. Mol Pharmacol. 2006 Jan;69(1):385-96. doi: 10.1124/mol.105.018465. Epub 2005 Oct 24. Mol Pharmacol. 2006. PMID: 16246908

6

Peroxisome proliferator-activated receptor-gamma and retinoic acid X receptor alpha represses the TGFbeta1 gene via PTEN-mediated p70 ribosomal S6 kinase-1 inhibition: role for Zf9 dephosphorylation.

Lee SJ, Yang EK, Kim SG. Lee SJ, et al. Among authors: kim sg. Mol Pharmacol. 2006 Jul;70(1):415-25. doi: 10.1124/mol.106.022954. Epub 2006 Apr 12. Mol Pharmacol. 2006. PMID: 16611854

7

Differential effects of the oxidized metabolites of oltipraz on the activation of CCAAT/enhancer binding protein-beta and NF-E2-related factor-2 for GSTA2 gene induction.

Ko MS, Lee SJ, Kim JW, Lim JW, Kim SG. Ko MS, et al. Among authors: kim sg, kim jw. Drug Metab Dispos. 2006 Aug;34(8):1353-60. doi: 10.1124/dmd.106.009514. Epub 2006 May 19. Drug Metab Dispos. 2006. PMID: 16714377

8

Inhibition of TGFbeta1-mediated PAI-1 induction by oltipraz through selective interruption of Smad 3 activation.

Cho IJ, Kim SH, Kim SG. Cho IJ, et al. Among authors: kim sg, kim sh. Cytokine. 2006 Sep;35(5-6):284-94. doi: 10.1016/j.cyto.2006.10.001. Epub 2006 Nov 13. Cytokine. 2006. PMID: 17095240

9

Metformin prevents an adaptive increase in GSH and induces apoptosis under the conditions of GSH deficiency in H4IIE cells.

Bae EJ, Cho MJ, Kim SG. Bae EJ, et al. Among authors: kim sg. J Toxicol Environ Health A. 2007 Aug;70(15-16):1371-80. doi: 10.1080/15287390701434430. J Toxicol Environ Health A. 2007. PMID: 17654257

10

Abrogation of hyperosmotic impairment of insulin signaling by a novel class of 1,2-dithiole-3-thiones through the inhibition of S6K1 activation.

Bae EJ, Yang YM, Kim SG. Bae EJ, et al. Among authors: kim sg. Mol Pharmacol. 2008 May;73(5):1502-12. doi: 10.1124/mol.107.044347. Epub 2008 Feb 5. Mol Pharmacol. 2008. PMID: 18252807

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,791 results

Search Page

Filters